Agitation and Clonus on Linezolid
Mrs. D is a 52-year-old woman with major depressive disorder who is admitted to hospital with a 3-day history of fever, confusion, and agitation. Her medications are venlafaxine 150 mg daily, trazodone 50 mg at bedtime, and linezolid 600 mg twice daily, which was started 4 days ago for MRSA pneumonia. On examination she is diaphoretic, tremulous, and disoriented. Temperature is 38.8°C, heart rate 122/min, blood pressure 156/92 mmHg, and respiratory rate 24/min. She has inducible clonus at the ankles and brisk deep tendon reflexes. Pupils are dilated. She has no rigidity, no focal neurologic deficit, and no meningismus. Labs show leukocytosis and elevated creatine kinase. She is not intubated. The admitting team asks whether this is neuroleptic malignant syndrome or serotonin syndrome.
1. What is the most likely diagnosis, and what are the immediate management priorities?
Read the worked answer
This is most consistent with serotonin syndrome due to linezolid combined with venlafaxine and trazodone. Linezolid is a reversible monoamine oxidase inhibitor and can precipitate serotonin toxicity when combined with serotonergic drugs. The key features are agitation, confusion, diaphoresis, tremor, hyperreflexia, inducible clonus, dilated pupils, fever, and tachycardia. Neuroleptic malignant syndrome is less likely because it typically causes lead-pipe rigidity, bradyreflexia, and hyporeflexia rather than clonus and hyperreflexia, and it follows dopamine antagonist exposure.
Immediate priorities are to stop all serotonergic agents and linezolid, provide supportive care, and monitor closely. Use intravenous fluids and benzodiazepines for agitation and autonomic instability. Active cooling is needed for hyperthermia. Do not give antipyretics as the primary treatment because the fever is due to increased muscle activity. Check serial creatine kinase, renal function, electrolytes, and coagulation; monitor for rhabdomyolysis, disseminated intravascular coagulation, and respiratory failure. If symptoms are moderate to severe, consider cyproheptadine, but it is not a substitute for stopping the offending agents. Avoid antipsychotics. Escalate to critical care if there is hyperthermia, rigidity, worsening confusion, or respiratory compromise.
2. How would you manage her depression and infection after stopping these agents?
Read the worked answer
The infection still requires treatment. Linezolid should be stopped and an alternative antibiotic chosen based on MRSA susceptibility and the source. Options may include vancomycin, clindamycin, or another agent guided by culture and local resistance patterns. Do not simply restart linezolid later with serotonergic antidepressants without specialist advice.
After the serotonin syndrome resolves, reassess her depression. Venlafaxine and trazodone should not be restarted immediately. If an antidepressant is needed, choose the lowest effective dose of an agent with lower serotonergic burden, such as mirtazapine or bupropion, after considering her previous response and comorbidities. Avoid combining multiple serotonergic drugs, including tramadol, triptans, St John’s wort, and some antiemetics. Document the adverse reaction clearly. Involve psychiatry and pharmacy. Educate the patient to tell all prescribers about this episode, because future linezolid exposure would be dangerous.
3. What monitoring and discharge planning are needed?
Read the worked answer
Monitor in a setting with telemetry and frequent neurologic checks until symptoms resolve. Track temperature, heart rate, blood pressure, muscle tone, clonus, and mental status. Repeat creatine kinase and renal function; watch for rhabdomyolysis and acute kidney injury. Monitor urine output and consider bladder catheterization if needed. If she develops severe hyperthermia, rigidity, or hypoxemia, transfer to intensive care for intubation and paralysis if necessary.
Before discharge, complete the antibiotic course with a safe alternative and confirm clinical improvement of pneumonia. Obtain psychiatric follow-up within 1–2 weeks. Reconcile all medications and flag linezolid as a contraindicated combination. Provide written information about serotonin syndrome symptoms. Counsel her to avoid over-the-counter serotonergic products and to inform pharmacy. Arrange primary care follow-up to review mood, sleep, and adherence. Document the reaction in the allergy/intolerance section so future teams do not inadvertently re-expose her.